近距离内射合集

I have spent more than a decade working as a physician assistant in hospitals and clinics across New Mexico. Over the years, I have treated patients in busy emergency departments, small rural practices and community health settings where resources are often stretched thin.

In medicine, we are trained to focus on diagnosis, evidence-based treatment and patient outcomes. Increasingly, one of the biggest obstacles to providing care is not figuring out what is wrong, but whether a patient can afford the medicine they need to get better. 

Too often, the moment of truth comes not in the exam room but at the pharmacy counter. A patient who has just left a visit feeling reassured returns days later, frustrated or frightened because the prescribed medication costs hundreds of dollars. Sometimes they never return at all. They simply try to cope without treatment.

When prescription drug prices are this high, medical decisions stop being about what is clinically best and start being about what is financially possible. Patients and practitioners know who鈥檚 to blame: Big Pharma, because it sets the prices that many Americans cannot afford. 

This challenge is a daily reality for healthcare providers nationwide. Physicians, nurse practitioners and physician assistants routinely find themselves rewriting prescriptions, searching for lower-cost alternatives, or delaying treatment while navigating insurance formularies and patient assistance programs.

Patients often assume that clinicians choose medications based purely on medical judgment. In truth, we are constantly balancing effectiveness with affordability. A drug may be the gold-standard treatment supported by years of research, but if a patient cannot afford it, that knowledge offers little comfort.

Healthcare providers should not have to compromise patient care because pharmaceutical prices are set far beyond what many families can reasonably pay.

These pressures are especially acute in underserved states. Those communities face higher poverty rates than the national average, vast rural distances between providers and limited healthcare infrastructure. For many patients, even relatively common medications can represent a serious financial burden.

I have cared for patients who have to choose which days to take pills to make prescriptions last longer. Others skip doses or delay filling a prescription until their next paycheck arrives. Some decide not to start treatment at all. These choices are rarely discussed openly, but they are deeply consequential. A condition that could be easily managed can quickly become severe when treatment is inconsistent or postponed.

Medical training emphasizes selecting therapies based on safety, effectiveness and the individual needs of each patient. Providers want to prescribe the treatment that gives someone the best chance of recovery or long-term stability. When prices are excessive, we are forced to practice medicine differently.

There is a professional frustration that comes with knowing what the right course of care should be and realizing it may not be realistic for the person sitting across from you. We meet patients who are trying to make difficult financial tradeoffs every day of our working lives.

Prescription drug pricing is often discussed in terms of innovation, market dynamics or insurance design. Those are important considerations. At its core, this issue is about whether patients can follow the treatment plans that healthcare providers recommend.

When medications are priced out of reach, people are less likely to follow prescribed regimens. Chronic illnesses become harder to control and emergency visits increase. Families may take on debt or sacrifice other essentials to pay for care. Over time, the ripple effects extend well beyond the healthcare system.

Reducing excessive drug prices would not solve every challenge facing American medicine. It would allow frontline providers to focus more fully on what we were trained to do: deliver the best possible care based on clinical evidence and patient needs.

We must confront the reality that affordability is shaping medical decisions in ways that put patients at risk.

Healthcare providers should be able to practice medicine based on what works best. Patients should be able to access the treatments that keep them healthy. They should not be overburdened with high costs due to Big Pharma鈥檚 greed. 

That will happen only when prescription drug pricing reflects not just market forces but the real-world effect those prices have on the lives of the people we serve.

Sofia Stewart-Young is a physician assistant who has practiced in hospitals and clinics across New Mexico. She wrote this for .